Monopar Therapeutics MNPR

$ 26.12 9.79%

Quarterly report 2024-Q3
added 11-08-2024

Monopar Therapeutics Financial Statements 2011-2024 | MNPR

Annual Financial Statements Monopar Therapeutics

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	9.4 M	35.6 M	38.5 M	93.9 M	157 M	-	-	-	-	-	-	-	-
Shares	13.8 M	12.7 M	12.5 M	11.1 M	9.32 M	-	-	-	-	-	-	-	-
Historical Prices	0.68	2.8	3.09	7.3	9.6	-	-	-	-	-	-	-	-
Net Income	-8.4 M	-10.5 M	-9.1 M	-6.3 M	-4.22 M	-3.23 M	-16.6 M	-1.19 M	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-8.83 M	-10.5 M	-9.13 M	-6.51 M	-4.32 M	-3.33 M	-16.6 M	-1.19 M	-	-	-	-	-
Interest Expense	429 K	21.2 K	24 K	81.9 K	98.9 K	103 K	48.3 K	7.23 K	-	-	-	-	-
EBITDA	-8.83 M	-10.5 M	-9.13 M	-6.63 M	-4.32 M	-3.4 M	-16.6 M	-1.19 M	-	-	-	-	-
Operating Expenses	8.83 M	10.5 M	9.13 M	6.51 M	4.32 M	3.4 M	16.6 M	-	-	-	-	-	-
General and Administrative Expenses	3.23 M	2.95 M	2.63 M	2.44 M	2.36 M	1.63 M	1.17 M	912 K	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Monopar Therapeutics

	2024-Q3	2024-Q2	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	3.52 M	17.5 M	2.98 M	2.82 M	13.4 M	13.2 M	12.9 M	12.8 M	12.6 M	12.6 M	12.6 M	12.6 M	12.6 M	12.1 M	11.5 M	11.1 M	10.6 M	10.6 M	10.6 M	9.29 M	9.29 M	9.29 M	9.29 M	9.29 M	9.29 M	9.29 M	9.29 M	8.87 M	8.62 M	8.34 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-1.3 M	-1.72 M	-	-1.95 M	-2.2 M	-2.43 M	-	-2.4 M	-2.76 M	-2.46 M	-	-2.46 M	-2.08 M	-1.88 M	-	-1.64 M	-1.45 M	-1.09 M	-	-736 K	-906 K	-1.38 M	-890 K	-640 K	-890 K	-890 K	-	-14.9 M	-591 K	-373 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-1.57 M	-1.79 M	-	-2.07 M	-2.33 M	-2.53 M	-	-2.41 M	-2.76 M	-2.46 M	-	-2.46 M	-2.09 M	-1.89 M	-	-1.65 M	-1.46 M	-1.14 M	-	-759 K	-932 K	-1.41 M	-	-668 K	-668 K	-897 K	-	-14.9 M	-595 K	-374 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	73.5 K	-	112 K	128 K	90.5 K	-	7.7 K	417	464	-	577	12.2 K	10.7 K	-	8.54 K	18.3 K	45.1 K	-	23.4 K	26.4 K	31.1 K	-	27.3 K	27.3 K	20.9 K	-	20.6 K	3.52 K	924	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-1.57 M	-1.79 M	-	-2.07 M	-2.33 M	-2.53 M	-	-2.41 M	-2.76 M	-2.46 M	-	-2.46 M	-2.09 M	-1.89 M	-	-1.65 M	-1.46 M	-1.14 M	-	-759 K	-932 K	-1.41 M	-	-668 K	-668 K	-897 K	-	-14.9 M	-595 K	-374 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	1.57 M	1.79 M	-	2.07 M	2.33 M	2.53 M	-	2.41 M	2.76 M	2.46 M	-	2.46 M	2.09 M	1.89 M	-	1.65 M	1.46 M	1.14 M	-	759 K	932 K	1.41 M	-	668 K	668 K	897 K	-	14.9 M	595 K	374 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	591 K	658 K	-	749 K	733 K	872 K	-	675 K	685 K	779 K	-	632 K	616 K	688 K	-	392 K	632 K	792 K	-	540 K	603 K	572 K	-	364 K	364 K	440 K	-	215 K	283 K	240 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency